A comprehensive view of Kraig Biocraft Laboratories Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.
Kraig Biocraft Laboratories completes rearing of first generation of its new BAM-1 parental strains as part of its spring production trial; Kraig Labs successfully produced recombinant cocoons at rates that exceeded trial expectations, control parameters
Published:
April 22, 2024
by GlobeNewswire
|
Kraig Biocraft Laboratories announces that spring production trials for the new BAM-1 hybrid have begun and are on track to meet company's expectations, timeline; BAM-1 is Kraig Labs' newest, most robust recombinant spider silk production silkworm hybrid
Published:
April 15, 2024
by Kraig Biocraft Laboratories Inc.
|
KRAIG BIOCRAFT LABORATORIES, INC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 01, 2024
by SEC Edgar Filings
|
KRAIG BIOCRAFT LABORATORIES, INC - (8-K) - Disclosing Unregistered Sales of Equity Securities
Published:
April 01, 2024
by SEC Edgar Filings
|
Kraig Biocraft Labs CEO 'encouraged' by RPI's method of creating spider silk protein from waste plastics; Kraig's recombinant spider silk production model is different, as RPI method uses new strain of bacteria to depolymerize PE into recombinant proteins
Published:
March 28, 2024
by Kraig Biocraft Laboratories Inc.
|
Ask us about our Logistic & Supply Chain market view